Revenue from Operations

Revenue from operations comprises revenue from manufacturing/production of Reagents, Machines and Medical equipment's to Distributors/customer across healthcare industry in both domestic market and customers located in different countries internationally. Our end customers include Hospitals, laboratories and diagnostic centres.

Other Income

Other income includes (i) Interest income on Fixed deposits; (ii) Profit on sale of investment in associate company; (iii) Profit on sale of fixed assets etc.

Expenses

Our expenses comprise (i) Cost of Material consumed; (ii) employee benefits expense; (iii) finance costs; (iv) depreciation and amortisation expense; and (v) other expenses.

Employee Benefit Expense

Employee benefit expenses primarily include (i) salaries wages and other expenses; (ii) director remuneration (iii) contributions to statutory fund; and (iv) staff welfare expenses (v) gratuity and leave encashment expenses.

Depreciation and Amortization expenses

Depreciation and amortization expenses primarily include depreciation expenses on our office Plant & machinery, Building, furniture and computers etc.

Other Expenses

Other expenses comprise (i) Factory Expenses & Consumables; (ii) Electricity Expenses; (iii) Repair & Maintenance expenses; (iv) Outsourcing charges (Recruitment); (v) CSR Expenses; (vi) Travelling Expense; (vii) Clearing and Forwarding Charges; (viii) Royalty Exp.; (ix) Professional Fees; (x) IT Support Expenses; (xi) Business Promotion Expenses; (xii) Bad debts; (xiii) Insurance Charges; (xv) Printing & Stationery; (xvi) other miscellaneous expenses;

Financial Performance Highlights for the Year Ended on March 31, 2025 (Based on Restated Financial Statements)

Total Income

Total income for the period ended on March 31, 2025 stood at ₹ 32258.42 Lakhs, which includes revenue from operation amounting to ₹ 20364.61 lakhs and other income of ₹ 280.20 lakhs.

Revenue from Operations

During the year ended on March 31, 2025 revenue from operations stood at ₹ 31378.04 Lakhs. The revenue from operations includes the revenue from manufacturing/production of Reagents, Machines and Medical equipment's to Distributors/customer across healthcare industry in both domestic market and customers located in different countries internationally. Our end customers include Hospitals, laboratories and diagnostic centres.

Other Income

During the year ended on March 31, 2025, other income was ₹ 880.38 Lakhs. Major portion of the other income includes interest income on FDR and write back of liabilities no longer required.

Cost of Material consumed

During the year ended on March 31, 2025, cost of material consumed stood at ₹ 14566.98 lakhs. This is the major portion of the total expenses of the company representing 45.16% of the total income of the Company.

Employee benefits expenses

Our Company has incurred ₹ 3031.59 Lakhs as employee benefits expense for the year ended on March 31, 2025.

Depreciation and amortization expenses